These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37990486)

  • 1. Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family.
    Chica-Redecillas L; Cuenca-Lopez S; Andres-Leon E; Terron-Camero LC; Cano-Gutierrez B; Cozar JM; Lorente JA; Vazquez-Alonso F; Martinez-Gonzalez LJ; Alvarez-Cubero MJ
    Cancer Commun (Lond); 2024 Mar; 44(3):443-447. PubMed ID: 37990486
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer.
    Fang S; Zhe S; Lin HM; Azad AA; Fettke H; Kwan EM; Horvath L; Mak B; Zheng T; Du P; Jia S; Kirby RM; Kohli M
    JCO Clin Cancer Inform; 2023 Jul; 7():e2300057. PubMed ID: 37490642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omic profiling reveals an RNA processing rheostat that predisposes to prostate cancer.
    Stentenbach M; Ermer JA; Rudler DL; Perks KL; Raven SA; Lee RG; McCubbin T; Marcellin E; Siira SJ; Rackham O; Filipovska A
    EMBO Mol Med; 2023 Jun; 15(6):e17463. PubMed ID: 37093546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer.
    Li R; Wang S; Cui Y; Qu H; Chater JM; Zhang L; Wei J; Wang M; Xu Y; Yu L; Lu J; Feng Y; Zhou R; Huang Y; Ma R; Zhu J; Zhong W; Jia Z
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32898860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
    Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
    Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-omic trip through the human gut.
    Quinn RA; Martin C; Guzior DV
    Nat Metab; 2023 May; 5(5):720-721. PubMed ID: 37165175
    [No Abstract]   [Full Text] [Related]  

  • 7. Convex Multi-View Clustering Via Robust Low Rank Approximation With Application to Multi-Omic Data.
    Shetta O; Niranjan M; Dasmahapatra S
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(6):3340-3352. PubMed ID: 34705655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data.
    Pellegrini M
    Sci Rep; 2023 May; 13(1):7875. PubMed ID: 37188913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic prediction of multi-omic traits.
    Koch L
    Nat Rev Genet; 2023 Jun; 24(6):346. PubMed ID: 37016044
    [No Abstract]   [Full Text] [Related]  

  • 11. Artificial intelligence uses multi-omic data to predict pancreatic cancer outcomes.
    Nat Cancer; 2024 Feb; 5(2):226-227. PubMed ID: 38279059
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape.
    Gui C; Wei J; Mo C; Liang Y; Cen J; Chen Y; Wang D; Luo J
    Int J Biol Sci; 2023; 19(12):3951-3969. PubMed ID: 37564213
    [No Abstract]   [Full Text] [Related]  

  • 13. A primer on correlation-based dimension reduction methods for multi-omics analysis.
    Downing T; Angelopoulos N
    J R Soc Interface; 2023 Oct; 20(207):20230344. PubMed ID: 37817584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omic genetic scores advance disease research.
    Chen C; Han L
    Trends Genet; 2023 Aug; 39(8):600-601. PubMed ID: 37295977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells.
    Wang Z; Li Y; Zhao W; Jiang S; Huang Y; Hou J; Zhang X; Zhai Z; Yang C; Wang J; Zhu J; Pan J; Jiang W; Li Z; Ye M; Tan M; Jiang H; Dang Y
    Signal Transduct Target Ther; 2023 May; 8(1):175. PubMed ID: 37121942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MoNET: an R package for multi-omic network analysis.
    Li J; Chen F; Liang H; Yan J
    Bioinformatics; 2022 Jan; 38(4):1165-1167. PubMed ID: 34694378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer and the genomic revolution: Advances using microarray analyses.
    Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE
    Mutat Res; 2005 Aug; 576(1-2):66-79. PubMed ID: 15950992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omic molecular profiling and network biology for precision anaesthesiology: a narrative review.
    Scarpa JR; Elemento O
    Br J Anaesth; 2023 Jul; 131(1):26-36. PubMed ID: 37055274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer analyses reveal multi-omic signatures and clinical implementations of the forkhead-box gene family.
    Bi X; Zheng D; Cai J; Xu D; Chen L; Xu Z; Cao M; Li P; Shen Y; Wang H; Zheng W; Wu D; Zheng S; Li K
    Cancer Med; 2023 Aug; 12(16):17428-17444. PubMed ID: 37401400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer genomics.
    Li PE; Nelson PS
    Curr Urol Rep; 2001 Feb; 2(1):70-8. PubMed ID: 12084298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.